Type 2 A (group II) von Willebrand disease mutations increase the susceptibility of VWF to ADAMTS-13.
Tsai
H-M
HM
D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; D004492:Edetic Acid / Q000494:pharmacology; D006801:Humans; D008666:Metalloendopeptidases / Q000378:metabolism*; D008970:Molecular Weight; D020125:Mutation, Missense / Q000502:physiology*; D014842:von Willebrand Diseases / Q000235:genetics*; D014841:von Willebrand Factor / Q000378:metabolism*
D014841:von Willebrand Factor; D004492:Edetic Acid; D051722:ADAM Proteins; D008666:Metalloendopeptidases; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human